Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Bafetinib

EU orphan designation number: EU/3/10/731
Active ingredient: Bafetinib
Indication: Treatment of chronic myeloid leukaemia
Sponsor: Eudax Srl
Polo Tecnologico, Via Fratelli Cuzio 42, 27100 Pavia, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan Designation EMEA/OD/143/09 (2010)3902 of 10/06/2010
12/09/2012 Change of address of sponsor EMEA/OD/143/09
05/07/2013 Removal of orphan designation from Community Register